📰 Development Kathrin Jansen News
Development Kathrin Jansen News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Development Kathrin Jansen. Real-time updates on events, politics, business and more.
January 26, 2022
Pfizer and BioNTech have begun a clinical trial for their Omicron-specific Covid-19 vaccine candidate, they announced in a news release on Tuesday.
January 26, 2022
The study will evaluate the vaccine for safety, tolerability and the level of immune response, as both a primary series and a booster dose.
January 25, 2022
CBS 58 is your local source for the Milwaukee news, Milwaukee weather, and Milwaukee sports.
January 25, 2022
Pfizer and BioNTech have begun a clinical trial for their Omicron-specific Covid-19 vaccine candidate, they announced in a news release on Tuesday.
January 25, 2022
Pfizer and BioNTech have begun a clinical trial for their Omicron-specific Covid-19 vaccine candidate, they announced in a news release on Tuesday.
January 25, 2022
"In the wake of omicron, we are proactively investigating and manufacturing at risk an omicron-based vaccine should it be needed," a spokesperson for Pfizer said.
January 25, 2022
Pfizer and BioNTech have begun a clinical trial for their Omicron-specific Covid-19 vaccine candidate, they announced in a news release on Tuesday.
January 25, 2022
"In the wake of omicron, we are proactively investigating and manufacturing at risk an omicron-based vaccine should it be needed," a spokesperson for Pfizer said.
January 25, 2022
"In the wake of omicron, we are proactively investigating and manufacturing at risk an omicron-based vaccine should it be needed," a spokesperson for Pfizer said.
January 25, 2022
"In the wake of omicron, we are proactively investigating and manufacturing at risk an omicron-based vaccine should it be needed," a spokesperson for Pfizer said.